| Literature DB >> 27528088 |
Talyta Galafassi Zarpelon1, Lúcio Mauro da Silva Guimarães1, Poliane Alfenas-Zerbini2, Eli Sidney Lopes3, Reginaldo Gonçalves Mafia4, Acelino Couto Alfenas5.
Abstract
Plant growth-promoting rhizobacteria strains from special formulations have been used to optimize eucalyptus cutting production. To undertake quality control for the formulated products, the rhizobacterial strains should be characterized to assess their purity and authentication. In the present study, we characterized nine strains of rhizobacteria, including three Bacillus subtilis (S1, S2 and 3918), two Pseudomonas sp. (MF4 and FL2), P. putida (MF2), P. fulva (Ca), Frateuria aurantia (R1), and Stenotrophomonas maltophilia (CIIb). The strains were differentiated by colony morphology after 24h of incubation in three different solid state culture media (glucose-nutritive agar, 523 medium and yeast extract-mannitol agar), sensitivity to a panel of 28 antibiotics (expressed according to the formation of inhibition halos of bacterial growth in the presence of antibiotics), and PCR-RFLP profiles of the 16S rDNA gene produced using nine restriction enzymes. It was possible to differentiate all nine strains of rhizobacteria using their morphological characteristics and sensitivity to antibiotics. The molecular analysis allowed us to separate the strains CIIb, FL2 and R1 from the strains belonging to the genera Bacillus and Pseudomonas. By using these three methods concomitantly, we were able to determine strain purity and perform the authentication.Entities:
Keywords: Biological product; Eucalyptus; Formulation; PGPR
Mesh:
Substances:
Year: 2016 PMID: 27528088 PMCID: PMC5052385 DOI: 10.1016/j.bjm.2016.07.013
Source DB: PubMed Journal: Braz J Microbiol ISSN: 1517-8382 Impact factor: 2.476
Fig. 1Patterns used for the morphological characterization of rhizobacterial strains based on their colony shape, elevation and edge type.
Morphological characterization of rhizobacterial strains assessed after 24 h of incubation in solid state glucose-nutritive agar (ANG), 523 medium and yeast extract-mannitol agar (YMA).
| Medium | Strain | Morphological characteristics | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Elevation | Shape | Edges | Color | Brightness | Growth | Size | Consistency | Surface | ||
| ANG | S1 | Spread | Circular | Complete | Light Beige | Opaque | Very fast | 1–2 mm | Mucosus | Smooth |
| S2 | Spread | Irregular | Dented | Beige | Opaque | Very fast | 1–2 mm | Mucosus | Rough | |
| 3918 | Flat | Irregular | Waved | Light Beige | Opaque | Very fast | 2–3 mm | Dried | Rough | |
| Ca | Convex – low | Irregular | Complete | Light Beige | Bright | Very fast | 1–2 mm | Mucosus | Smooth | |
| CIIb | Convex – high | Pointed | Complete | Light Beige | Bright | Very fast | <1 mm | Mucosus | Smooth | |
| R1 | Flat | Pointed | Complete | Light Beige | Bright | Fast | 1–2 mm | Mucosus | Smooth | |
| FL2 | Flat | Circular | Complete | Yellow-orange | Translucent | Very fast | >3 mm | Mucosus | Smooth | |
| MF2 | Umbilical | Circular | Complete | Dark Beige | Bright | Very fast | 1–2 mm | Mucosus | Smooth | |
| MF4 | Central protrusion | Circular | Complete | Beige-yellow | Bright | Very fast | 1–2 mm | Mucosus | Smooth | |
| 523 | S1 | Convex – low | Circular | Complete | Beige | Bright | Very fast | >3 mm | Mucosus | Rough |
| S2 | Convex – low | Circular | Complete | Light Beige | Bright | Very fast | >3 mm | Fluid | Smooth | |
| 3918 | Umbilical | Circular | Complete | White-ice | Bright | Very fast | >3 mm | Fluid | Rough | |
| Ca | Umbilical | Circular | Waved | Beige-green | Bright | Very fast | >3 mm | Mucosus | Smooth | |
| CIIb | Convex – medium | Pointed | Complete | White | Bright | Very fast | <1 mm | Mucosus | Smooth | |
| R1 | Flat | Circular | Dented | Beige | Bright | Fast | 1–2 mm | Mucosus | Smooth | |
| FL2 | Flat | Circular | Complete | Green-fluorescent | Translucent | Very fast | >3 mm | Mucosus | Smooth | |
| MF2 | Convex – low | Circular | Complete | Yellow-green | Bright | Very fast | 1–2 mm | Mucosus | Smooth | |
| MF4 | Umbilical | Circular | Complete | Beige-yellow | Bright | Very fast | 2–3 mm | Mucosus | Smooth | |
| YMA | S1 | Flat | Circular | Lobed | White | Opaque | Very fast | >3 mm | Dried | Rough |
| S2 | Flat | Irregular | Dented | Beige | Opaque | Very fast | >3 mm | Dried | Rough | |
| 3918 | Flat | Irregular | Waved | White | Opaque | Very fast | >3 mm | Dried | Rough | |
| Ca | Flat | Irregular | Complete | Beige-yellow | Bright | Very fast | >3 mm | Mucosus | Smooth | |
| CIIb | Convex – high | Pointed | Complete | White | Bright | Very fast | <1 mm | Mucosus | Smooth | |
| R1 | Flat | Pointed | Complete | Light Beige | Bright | Fast | 1–2 mm | Mucosus | Smooth | |
| FL2 | Flat | Circular | Complete | Yellow-orange | Translucent | Very fast | 2–3 mm | Mucosus | Smooth | |
| MF2 | Central protrusion | Circular | Complete | Beige | Bright | Very fast | 1–2 mm | Mucosus | Smooth | |
| MF4 | Convex – medium | Circular | Complete | Beige-yellow | Bright | Very fast | 2–3 mm | Mucosus | Smooth | |
Rhizobacterial strain sensitivity expressed according to the formation of inhibition halos of bacterial growth in the presence of antibiotics.
| Antibiotic | Rhizobacterial strains | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Commercial name | Concentration | S1 | S2 | 3918 | Ca | CIIb | R1 | FL2 | MF2 | MF4 |
| Pefloxacin | 5 mcg | + | + | + | + | + | + | + | + | + |
| Penicillin G | 10 U | − | − | − | − | − | + | − | − | − |
| Amikacin | 30 μg | + | + | + | + | + | + | − | + | + |
| Amoxycillin + clavulanic acid | 30 mcg | + | + | + | + | + | + | − | + | + |
| Cefepime | 30 μg | + | + | + | + | + | + | − | + | + |
| Cefotaxime | 30 mcg | + | + | + | + | + | + | − | + | + |
| Norfloxacin | 10 μg | + | + | + | + | + | + | − | + | + |
| Sulphazotrim | 25 μg | + | + | + | − | + | + | − | − | − |
| Clindamycin | 2 μg | + | + | + | − | + | + | − | − | − |
| Vancomycin | 30 mcg | + | + | + | − | + | + | − | − | − |
| Oxacillin | 1 μg | + | + | + | − | − | − | − | − | − |
| Rifampicin | 5 μg | − | + | − | − | + | − | − | + | + |
| Tobramycin | 10 μg | − | + | − | + | − | + | − | + | + |
| Aztreonam | 30 μg | − | + | + | − | − | − | − | + | + |
| Cefalotin | 30 μg | − | + | + | − | − | + | − | − | − |
| Ceftazidime | 30 μg | − | + | + | + | + | + | − | + | + |
| Cephalexin | 30 mcg | + | − | + | + | − | + | − | − | − |
| Ampicillin | 10 μg | + | + | − | + | + | + | − | − | − |
| Chloramphenicol | 30 μg | + | + | − | + | + | + | − | − | − |
| Erythromycin | 15 μg | + | + | − | − | − | + | − | − | − |
| Nitrofurantoin | 300 μg | + | + | − | − | − | + | − | + | − |
| Amoxycillin | 10 μg | + | + | − | + | + | + | − | + | − |
| Pipemidic acid | 20 mcg | + | + | − | + | + | + | + | − | + |
| Streptomycin | 10 mcg | + | + | + | + | − | + | + | − | + |
| Neomycin | 30 mcg | + | + | + | + | − | + | − | + | − |
| Tetracycline | 30 μg | − | + | − | + | + | + | + | − | + |
| Ticarcillin + clavulanic acid | 85 mcg | + | + | + | + | + | + | − | − | + |
| Sulfonamide | 300 μg | + | + | + | + | + | + | + | − | + |
Absence of inhibition halo (−).
Presence of inhibition halo (+).
Fig. 2Restriction profile of amplified fragments of the 16S region from the rDNA of nine rhizobacterial strains. The fragments were cleaved with the following restriction enzymes: (A) EcoRI, (B) RsaI, (C) Sau3AI, (D) SphI, (E) MspI, (F) BamHI, (G) DdeI, (H) HinfI, (I) TaqI, and (M) restriction enzyme – 1 kb Plus DNA Ladder.